Premium
A novel panel of protein biomarkers for predicting response to thalidomide‐based therapy in newly diagnosed multiple myeloma patients
Author(s) -
Rajpal Rajesh,
Dowling Paul,
Meiller Justine,
Clarke Colin,
Murphy William G.,
O'Connor Robert,
Kell Malcolm,
Mitsiades Constantine,
Richardson Paul,
Anderson Kenneth C.,
Clynes Martin,
O'Gorman Peter
Publication year - 2011
Publication title -
proteomics – clinical applications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.948
H-Index - 54
eISSN - 1862-8354
pISSN - 1862-8346
DOI - 10.1002/prca.201190073
Subject(s) - thalidomide , multiple myeloma , medicine , myeloma protein , oncology
This article was originally published in Proteomics 2011, 11 , 1391–1402, DOI 10.1002/pmic.201000471
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom